R562Q (p.Arg562Gln) variant of SMO (Protein smoothened)

R562Q (p.Arg562Gln) in SMO (Protein smoothened) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Basal cell carcinoma, somatic. The available variant effect predictions contribute to a CATVariant prioritization score of 0.67 / 1. The record also includes population frequency data, published literature, and structural context.

R562Q (p.Arg562Gln) variant details